Amlodipine

CHEBI:CHEBI_2668

Definition

A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Chemical Information

Molecular Formula
C20H25ClN2O5
Molecular Mass
408.87600
Charge
0
SMILES
CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC
InChI
InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3
InChIKey
HTIQEAQVCYTUBX-UHFFFAOYSA-N

Alternative Names

  • 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
  • 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
  • amlodipine
  • Amlodipine Free Base
  • amlodipino
  • amlodipinum

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
17767
oboInOwl#hasDbXref
Wikipedia:Amlodipine
core#notation
CHEBI:2668

Additional References

Wikipedia:Amlodipine

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

brand_name_base
Katerzia
product_ndc
63187-326
brand_name
Lotrel
listing_expiration_date
20241231
spl_id
0e8788cc-8c04-6f26-e063-6294a90a9a81
marketing_start_date
20170718
package_description
1000 TABLET in 1 BOTTLE (52605-042-10)
package_ndc
53104-7561-1
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
dosage_form
SUSPENSION
application_number
NDA211340
manufacturer_name
Daiichi Sankyo Inc.
package_marketing_start_date
20240513
labeler_name
Daiichi Sankyo Inc.
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
17767
generic_name
Amlodipine Besylate (Process 1)
oboInOwl#hasDbXref
Wikipedia:Amlodipine
oboInOwl#id
CHEBI:2668
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_38215
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
BFO_0000053
http://purl.obolibrary.org/obo/DRON_00020325
rxcui
898348
unii
XD75TQ8A2P
spl_set_id
f5c6c095-3b68-17f3-e053-2a95a90ad160
has_treatment
http://purl.obolibrary.org/obo/DOID_0070233
route
ORAL
core#notation
CHEBI:2668
pharm_class_epc
Dihydropyridine Calcium Channel Blocker [EPC]
pharm_class
Dihydropyridines [CS]
pharm_class_pe
Increased Diuresis [PE]
pharm_class_cs
Dihydropyridines [CS]
pharm_class_moa
Calcium Channel Antagonists [MoA]
brand_name_suffix
2.5 mg
upc
0360505347933
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
active_ingredient_name
AMLODIPINE BENZOATE
active_ingredient_strength
35 kg/35kg
nui
N0000175566
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_113394
owl#annotatedSource
t155659
owl#someValuesFrom
t3866940